Oncquest Laboratories Limited

Oncquest Laboratories Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24233DL2007PLC170898 Incorporated 29 November 2007 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company healthcare MSME · Medium
Revenue · FY 2025
₹97.99 Cr
▲ 0.27% YoY
Net loss · FY 2025
₹40.75 Cr
Net margin -41.6%
EBITDA · FY 2025
-₹26.73 Cr
EBITDA margin -27.3%
Authorised capital
₹38 Cr
Registered with MCA
Paid-up capital
₹38 Cr
Issued & subscribed
Company age
19 yrs
Est. 2007
Employees · EPFO
533
Provident fund records
Directors on board
4
As per MCA filings

About Oncquest Laboratories Limited

Data last updated:

Oncquest Laboratories Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Milky Investment & Trading Co. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 29 November 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2007PLC170898. Its GSTIN is 07AAACO9860B1ZI (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹38 Cr and a paid-up capital of ₹38 Cr. It was formerly known as Oncquest Laboratories Private Limited. It is led by directors including Aditya Chand Burman and Rajiv Kapoor.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, India – 110002.

As per the financials filed for FY 2025, the company reported a revenue of ₹97.99 Cr. For the same year it recorded a net loss of ₹40.75 Cr (net margin -41.6%) and EBITDA of -₹26.73 Cr (EBITDA margin -27.3%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.

The company has about 533 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Oncquest and Oncquest Laboratories. Court records list 14 cases involving the company, including 11 filed by the company and 3 filed against it; 8 cases are pending. The company has 7 deals on record (4 acquisitions, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹55.96 Cr; the latest was in January 2025. Its 3 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 2 larger and 1 smaller; the largest is Datar Cancer Genetics Private Limited with revenue of ₹102.27 Cr. The company has 21 MSME Form 1 returns on record between 2019 and 2024, listing 11,261 overdue payments to 199 micro and small suppliers.

Oncquest Laboratories Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0017881). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website oncquest.net.

Company details

CIN U24233DL2007PLC170898
Registration Number 170898
Incorporation Date 29 November 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Parent Company Milky Investment & Trading Co
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-01-0017881

CIN history

Oncquest Laboratories has one previous CIN (Corporate Identification Number): U24233DL2007PTC170898. The current CIN is U24233DL2007PLC170898, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24233DL2007PLC170898Current
U24233DL2007PTC170898Previous
Key People
Aditya Chand Burman Director Rajiv Kapoor Director Gaurav Chamaria Director

Recognitions & Rankings of Oncquest Laboratories

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-DL-01-0017881

Contact details

Oncquest Laboratories Limited's registered office is in New Delhi, Delhi. Its website is oncquest.net. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    oncquest.net
  • Social Media
  • Registered Address
    First Floor Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, India – 110002
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Oncquest Laboratories Limited, buy the company report.

Comprehensive company report
Oncquest Laboratories Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Oncquest Laboratories operates two associated brands: Oncquest and Oncquest Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Oncquest
Operates a chain of pathology laboratory centers providing diagnostic services.oncquestlabs.com
Oncquest Laboratories
Chain of diagnostic labsoncquest.net

Business activity

The main business activity of Oncquest Laboratories is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Oncquest Laboratories Limited, buy the company report.

Financials of Oncquest Laboratories Limited

FY 2025 filings available

Oncquest Laboratories Limited reported revenue of ₹97.99 Cr for FY 2025.

Revenue · FY 2025
₹97.99 Cr
Net loss · FY 2025
₹40.75 Cr margin -41.6%
EBITDA · FY 2025
-₹26.73 Cr margin -27.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 2%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 47%
3 years · compounded
▲ 3%
5 years · compounded
▼ 42%

Revenue has grown at a compounded annual rate (CAGR) of 1% over five years. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹26.73 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹40.75 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-27.3%
Net Profit Margin-41.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Oncquest Laboratories Limited, buy the company report.

Board of directors of Oncquest Laboratories Limited

Oncquest Laboratories has 4 current directors and 23 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Aditya Chand Burman
Also directs: Dabur India Limited, Eveready Industries India Ltd, A.Cee Enterprises (A Private Company With Unlimited Liability) and 3 more
Director29 Nov 200718 Years 11 MonthsCurrent
Rajiv KapoorDirector23 Jan 20242 Years 9 MonthsCurrent
Gaurav Chamaria
Also directs: A.Cee Enterprises (A Private Company With Unlimited Liability), Tag Partners LLP, Blackburrow Agritech Private Limited and 5 more
Director26 Oct 20233 Years 0 MonthsCurrent
Naresh Chander Arora
Also directs: Northern Aromatics Private Limited., Elephant India Finance Private Limited, Indiamo Private Limited
Director16 May 20251 Years 5 MonthsCurrent
View all directors

Peer comparison

Oncquest Laboratories Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Datar Cancer Genetics Private Limited₹102.27 Cr (FY 2025)31.0%Nashik, Maharashtra, India
Lupin Diagnostics Limited₹98.57 Cr (FY 2025)42.0%Mumbai, Maharashtra, India
Oncquest Laboratories Limitedthis company₹97.99 Cr (FY 2025)-₹40.75 Cr-41.6%533New Delhi, Delhi, India
Accuprobe Healthcare and Diagnostics Private Limited₹94.78 Cr (FY 2025)35.0%Delhi, India

To see the full peer comparison of Oncquest Laboratories Limited, buy the company report.

Auditor

Oncquest Laboratories Limited is audited by T R Chadha & Co LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
T R Chadha & Co LLPFY 2023006711N/N500028

Shareholding

The shareholding of Oncquest Laboratories Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Oncquest Laboratories Limited, buy the company report.

Deals & funding

Oncquest Laboratories Limited has 7 deals on record (4 acquisitions, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹55.96 Cr; the latest was in January 2025.

Total deals
7
Acquisitions
4
Funding round
1
Secondary share transfer
1
Convertible or debt financing
1
Disclosed funding
₹55.96 Cr

Deals on record (5 of 7)

WhenDealAmountParties
Aug 2023Acquisition₹146.47 CrBuyer: Burman Family Holdings
Mar 2022Acquisition₹23.83 CrBuyer: Burman Family Holdings
Mar 2014Acquisition₹33.83 CrBuyer: Burman Family Holdings
Dec 2011Funding round₹5 CrInvestors: Burman Family Holdings
May 2009Secondary share transferUndisclosedBuyer: Burman Family Holdings, Puran Associates Private Limited & Minnie Burman
Seller: Puran Associates Private Limited & Shivani Burman, Puran Associates Private Limited & Aditya Burman, Puran Associates Private Limited & Sudha Burman

To see the full deal history of Oncquest Laboratories Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Oncquest Laboratories Limited has 21 MSME Form 1 returns on record between 2019 and 2024, listing 11,261 overdue payments to 199 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 199)

SupplierAmount dueDue sinceReported on
an individual supplier
Credent Connect N Care Limited
Goodwill Diagnostics
Solution One
Embee Diagnostics Private Limited

To see the full MSME payment records of Oncquest Laboratories Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Oncquest Laboratories has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Associated companies

Employees & EPFO

Oncquest Laboratories Limited has a workforce of 533 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
533
Active EPFO establishments
1
Employee growth
-10.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27533
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Oncquest Laboratories Limited, buy the company report.

GST

Oncquest Laboratories has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AAACO9860B1ZIDelhiActive01 Jul 2017
06AAACO9860B1ZKHaryanaActive24 Feb 2022

To see the full GST registrations and return filing status of Oncquest Laboratories Limited, buy the company report.

Recent activity

Oncquest Laboratories Limited has 25 board changes on record since 2007: 6 appointments and 19 cessations. The latest: Naresh Chander Arora ceased to be Additional Director on 28 Sep 2025.

AGM
Oncquest Laboratories Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Ceased
Naresh Chander Arora ceased to be Additional Director.
Ceased
Prashant Kumar Balodia ceased to be Additional Director.
Appointed
Naresh Chander Arora was appointed as Director.
Filing
Oncquest Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Dipanngshu Sannyal ceased to be Manager.
Appointed
Swati Rawat was appointed as Company Secretary.
Ceased
Gaurav Chamaria ceased to be Additional Director.
Ceased
Rajiv Kapoor ceased to be Additional Director.
Ceased
Rohit Katyal ceased to be Company Secretary.
Appointed
Rajiv Kapoor was appointed as Director.
Appointed
Vandana Wadhwa was appointed as CFO.

16 earlier events are in the company report.

News

Frequently asked questions

Oncquest Laboratories is an active public limited company based in New Delhi, Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 29 November 2007 (19+ years old) and is registered under CIN U24233DL2007PLC170898.

Oncquest Laboratories has 4 current directors:

The latest financial statements of Oncquest Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Oncquest Laboratories is 07AAACO9860B1ZI, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAACO9860B1ZK (Haryana).

The CIN (Corporate Identification Number) of Oncquest Laboratories is U24233DL2007PLC170898. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Oncquest Laboratories has 14 court cases on record: 11 filed by the company and 3 filed against it. 8 are pending. Most are in the high courts.

Oncquest Laboratories was incorporated on 29 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.

Oncquest Laboratories has 7 deals on record (4 acquisitions, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹55.96 Cr; the latest was in January 2025.

The peers of Oncquest Laboratories by revenue are Datar Cancer Genetics Private Limited, Lupin Diagnostics Limited, Accuprobe Healthcare and Diagnostics Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).

Naresh Chander Arora ceased to be Additional Director on 28 Sep 2025. Prashant Kumar Balodia ceased to be Additional Director on 10 Jul 2025. Naresh Chander Arora was appointed as Director on 16 May 2025. Oncquest Laboratories has 25 board changes on record in total.

Yes, Oncquest Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-01-0017881).

Oncquest Laboratories has 21 MSME Form 1 returns on record between 2019 and 2024, listing 11,261 overdue payments to 199 micro and small suppliers. The latest return was filed on 01 May 2024.